In biotech, observes Vir Biotechnology president and CEO George Scangos, it’s especially crucial to fully understand the market, and the means by which a new therapy will be purchased, prescribed and distributed. Many scientifically successful drugs, he points out, have been commercial failures—further demonstrating the importance of making sure the market is prepared to accept (and pay for) a new therapy.
Related
Maëlle Gavet,
Techstars
Ruthless Empathy [Entire Talk]
Empathetic technology can empower companies to scale social good.
Maëlle Gavet,
Techstars
Ruthless Empathy [Entire Talk]
Empathetic technology can empower companies to scale social good.
Hemant Taneja,
General Catalyst
Build, Don’t Break [Entire Talk]
The bigger the impact, the greater the responsibility.
Hemant Taneja,
General Catalyst
Build, Don’t Break [Entire Talk]
The bigger the impact, the greater the responsibility.
Aicha Evans,
Zoox
Driving Innovation [Entire Talk]
Execute bold ideas with conviction.
Aicha Evans,
Zoox
Driving Innovation [Entire Talk]
Execute bold ideas with conviction.
